Nasdaq · Healthcare
VIEMED HEALTHCARE, INC. (VMD)
As-reported financials and recent SEC filings for VIEMED HEALTHCARE, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$270.3M
Net income
$14.9M
Net margin
5.5%
Diluted EPS
$0.37
ROE
10.4%
P/E (TTM)
31.4×
Market cap
$445.9M
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M |
| Gross profit | $155.5M | $133.2M | $112.8M | $84.7M | $73.4M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M |
| Diluted EPS | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →8-K2026-06-04
View on EDGAR →8-K2026-06-02
View on EDGAR →10-Q2026-05-05
View on EDGAR →8-K2026-05-05
View on EDGAR →DEF 14A2026-04-22
View on EDGAR →DEFA14A2026-04-22
View on EDGAR →Go deeper on VMD
Search VIEMED HEALTHCARE, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.